Global Adult Vaccines Market Report 2024

Adult Vaccines Global Market Report 2024 – By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated Vaccines, Inactivated Viral or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines), By Application (Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis), By End Users (Healthcare Firms, Hospitals) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Adult Vaccines Market

Proud Members Of

checkslacipN checkaoirsN checkscipN

Adult Vaccines Market Definition And Segments

Adult vaccines refer to the vaccines that are used to induce an immune response against a disease causing pathogen in adults. These vaccines are used for preventing and treating diseases such as influenza, pneumococcal disease, and herpes.

The main types of adult vaccines are monovalent and multivalent. A monovalent vaccine refers to a vaccine that contains the mRNA component of a single virus and generates an immune response for a single antigen. The technologies involved are live attenuated vaccines, inactivated viral or bacterial vaccines, toxoid vaccines, recombinant vaccines, and conjugate vaccines. These are used in several applications, such as influenza, dPT, the human papillomavirus, zoster, pneumococcal disease, and hepatitis, and are used by healthcare firms and hospitals.

The adult vaccines market covered in this report is segmented –

1) By Vaccine Type: Monovalent, Multivalent

2) By Technology: Live Attenuated Vaccines, Inactivated Viral or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines

3) By Application: Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis

4) By End Users: Healthcare Firms, Hospitals

The adult vaccines market size has grown strongly in recent years. It will grow from $21.48 billion in 2023 to $23.09 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing aging population, government vaccination programs, growing awareness of preventive healthcare, vaccine development and innovation, public health campaigns.

The adult vaccines market size is expected to see strong growth in the next few years. It will grow to $32.13 billion in 2028 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to emergence of new infectious threats, increasing focus on immunization registries, rising threat of antimicrobial resistance, global efforts for pandemic preparedness, shift toward personalized vaccines, increased focus on maternal immunization. Major trends in the forecast period include digital health integration, technological advancements in vaccine production, collaborations between governments and pharmaceutical companies, advancements in vaccine delivery technologies, expanding immunization programs.

Rising Prevalence Of Contagious Diseases Drives Growth In Adult Vaccine Market

The increasing prevalence of contagious diseases is driving the adult vaccine market forward. Contagious diseases are diseases that spread from person to person. Vaccines help the person to develop immunity against contagious diseases and therefore are a very effective mechanism for fighting infections. For instance, in December 2022, according to the World Health Organization’s COVID-19 dashboard, a Switzerland-based public health agency of the United Nations, 655 million people were infected with COVID-19 since the emergence of the virus in 2019. Furthermore, in 2021, according to the global tuberculosis report published by the World Health Organization, a Switzerland-based international public health agency of the United Nations, 1.3 million deaths (Non-HIV) occurred due to TB (Tuberculosis) which was up from 1.2 million in 2019. Therefore, the increasing prevalence of contagious diseases is driving the growth of the adult vaccines market.

Rising Healthcare Expenditure Drives Growth In Adult Vaccine Market

The increased healthcare expenditure supported the growth of the adult vaccine market. Healthcare expenditure refers to the total cost of healthcare services provided to a population. Increased healthcare expenditure often leads to greater funding for medical research and development. By investing in vaccination programs and increasing access to vaccines, healthcare systems can reduce the burden of preventable diseases and improve overall population health. Additionally, adult vaccination can lead to significant cost savings by reducing healthcare utilization and the need for expensive treatments. For example, in the Economic Survey of 2022, an annual document of the Ministry of Finance, Government of India, India’s public expenditure on healthcare stood at 2.1% of GDP in 2021–22, against 1.8% in 2020–21. Therefore, the increased healthcare expenditure positively impacted the growth of the adult vaccine market.

Major companies operating in the adult vaccines market report are GlaxoSmithKline PLC, Merck & Co, Sanofi Pasteur, Pfizer Inc., Commonwealth Serum Laboratories Limited, Johnson & Johnson, Serum Institute of India, AstraZeneca PLC, Novartis AG, Protein Sciences Corporation, Emergent BioSolutions Inc., Bavarian Nordic A/S, Dynavax Technologies Corporation, Novavax Inc., Medimmune, BioNTech SE, Moderna, Inovio Pharmaceuticals, Sinovac, Valneva Se, Bharat Biotech, Biological E Limited, Panacea Biotec, Shenzhen Kangtai Biological Products, Beijing Tiantan Biological Products, Hualan Biological Engineering, Chengdu Institute of Biological Products, Bharat Biotech International Limited, Protein Sciences Corporation, Takeda Pharmaceutical Company Limited .

Data Trend Platform To Enhance Adult Vaccination Efforts

Product innovations are a key trend gaining popularity in the adult vaccines market. Major companies in the market are introducing innovative products to sustain their position in the market. For instance, in August 2022, GSK, a UK-based biopharma company, and IQVIA, an India-based global provider of advanced analytics, technology solutions, and clinical research services, launched Vaccine Track, a data trend platform to help improve adult vaccination in communities nationwide. This resource will provide frequent and relevant data on trends to focus on and enhance public health efforts.

Merck & Co., Inc. And Moderna Collaborate To Advance Personalized Cancer Vaccine

Major companies operating in the adult vaccine market are focusing on strategic collaborations to develop and commercialize personalized cancer vaccine. Strategic collaborations are a type of business relationship in which two or more companies agree to work together to achieve common goals. For instance, in October 2022, Merck & Co., Inc., an American multinational pharmaceutical company, and Moderna, a US-based pharmaceutical and biotechnology company, entered into a collaboration to jointly develop and commercialize personalized cancer vaccine (PCV) mRNA-4157/V940 pursuant to the terms of their existing collaboration and license agreement. mRNA-4157/V940 is currently being evaluated in combination with KEYTRUDA, Merck’s anti-PD-1 therapy, as adjuvant treatment for patients with high-risk melanoma in a Phase 2 clinical trial being conducted by Moderna.

GSK Expands Vaccine Portfolio With Acquisition Of Affinivax, Inc., Strengthening Focus On Innovative Pneumococcal And Adult Vaccines

In August 2022, GSK, a UK-based pharmaceutical company, acquired Affinivax, Inc., for an undisclosed amount. This acquisition is expected to align with GSK’s strategy of building a strong portfolio of specialty medicines and vaccines, including innovative vaccine candidates for pneumococcal disease. Affinivax, Inc. is a US-based clinical-stage biopharmaceutical company that has developed next-generation pneumococcal vaccines and adult vaccines based on the Multiple Antigen Presenting System (MAPS) platform technology.

North America was the largest region in the adult vaccines market in 2023. Asia-Pacific is expected to be the fastest-growing region in the adult vaccines market during the forecast period. The regions covered in the adult vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the adult vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The adult vaccines market consists of sales of mRNA vaccines and viral vector vaccines. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The adult vaccines market research report is one of a series of new reports from The Business Research Company that provides adult vaccines market statistics, including adult vaccines industry global market size, regional shares, competitors with a adult vaccines market share, detailed adult vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the adult vaccines industry. This adult vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

    Table Of Contents

    1. Executive Summary

    2. Adult Vaccines Market Characteristics

    3. Adult Vaccines Market Trends And Strategies

    4. Adult Vaccines Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Adult Vaccines Market Size and Growth

    5.1. Global Adult Vaccines Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Adult Vaccines Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Adult Vaccines Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Adult Vaccines Market Segmentation

    6.1. Global Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Monovalent

    Multivalent

    6.2. Global Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Live Attenuated Vaccines

    Inactivated Viral or Bacterial Vaccines

    Toxoid Vaccines

    Recombinant Vaccines

    Conjugate Vaccines

    6.3. Global Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Influenza

    DPT

    Human Papillomavirus

    Zoster

    Pneumococcal

    Hepatitis

    6.4. Global Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Healthcare Firms

    Hospitals

    7. Adult Vaccines Market Regional And Country Analysis

    7.1. Global Adult Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Adult Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Adult Vaccines Market  

    8.1. Asia-Pacific Adult Vaccines Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Adult Vaccines Market  

    9.1. China Adult Vaccines Market Overview  

    9.2. China Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Adult Vaccines Market  

    10.1. India Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Adult Vaccines Market  

    11.1. Japan Adult Vaccines Market Overview  

    11.2. Japan Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Adult Vaccines Market  

    12.1. Australia Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Adult Vaccines Market  

    13.1. Indonesia Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Adult Vaccines Market  

    14.1. South Korea Adult Vaccines Market Overview  

    14.2. South Korea Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Adult Vaccines Market  

    15.1. Western Europe Adult Vaccines Market Overview

    15.2. Western Europe Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Adult Vaccines Market  

    16.1. UK Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Adult Vaccines Market  

    17.1. Germany Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Adult Vaccines Market  

    18.5. France Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Adult Vaccines Market  

    19.9. Italy Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Adult Vaccines Market  

    20.13. Spain Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Adult Vaccines Market  

    21.1. Eastern Europe Adult Vaccines Market Overview

    21.2. Eastern Europe Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Adult Vaccines Market  

    22.1. Russia Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Adult Vaccines Market  

    23.1. North America Adult Vaccines Market Overview

    23.2. North America Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Adult Vaccines Market  

    24.1. USA Adult Vaccines Market Overview

    24.2. USA Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Adult Vaccines Market  

    25.1. Canada Adult Vaccines Market Overview

    25.2. Canada Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Adult Vaccines Market  

    26.1. South America Adult Vaccines Market Overview

    26.2. South America Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Adult Vaccines Market  

    27.1. Brazil Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Adult Vaccines Market  

    28.1. Middle East Adult Vaccines Market Overview

    28.2. Middle East Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Adult Vaccines Market  

    29.1. Africa Adult Vaccines Market Overview

    29.2. Africa Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Adult Vaccines Market Competitive Landscape And Company Profiles

    30.1. Adult Vaccines Market Competitive Landscape

    30.2. Adult Vaccines Market Company Profiles

    30.2.1. GlaxoSmithKline PLC

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Merck & Co

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Sanofi Pasteur

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Pfizer Inc

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Commonwealth Serum Laboratories Limited

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Adult Vaccines Market Competitive Benchmarking

    32. Global Adult Vaccines Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Adult Vaccines Market

    34. Adult Vaccines Market Future Outlook and Potential Analysis

    34.1 Adult Vaccines Market In 2028 - Countries Offering Most New Opportunities

    34.2 Adult Vaccines Market In 2028 - Segments Offering Most New Opportunities

    34.3 Adult Vaccines Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Adult Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Adult Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: GlaxoSmithKline PLC Financial Performance
  • Table 76: Merck & Co Financial Performance
  • Table 77: Sanofi Pasteur Financial Performance
  • Table 78: Pfizer Inc Financial Performance
  • Table 79: Commonwealth Serum Laboratories Limited Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Adult Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Adult Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: GlaxoSmithKline PLC Financial Performance
  • Figure 76: Merck & Co Financial Performance
  • Figure 77: Sanofi Pasteur Financial Performance
  • Figure 78: Pfizer Inc Financial Performance
  • Figure 79: Commonwealth Serum Laboratories Limited Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the adult vaccines market?

Adult vaccines refer to the vaccines that are used to induce an immune response against a disease causing pathogen in adults. These vaccines are used for preventing and treating diseases such as influenza, pneumococcal disease, and herpes. For further insights on the adult vaccines market, request a sample here

How will the adult vaccines market drivers and restraints affect the adult vaccines market dynamics? What forces will shape the adult vaccines industry going forward?

The adult vaccines market growth is aided by increasing prevalence of contagious diseases For further insights on the adult vaccines market, request a sample here

What is the forecast market size or the forecast market value of the adult vaccines market?

The adult vaccines market is expected to reach $25.83 billion in 2027 at a rate of 7.20% For further insights on the adult vaccines market, request a sample here

How is the adult vaccines market segmented?

The global adult vaccines market is segmented as
1) By Vaccine Type: Monovalent, Multivalent
2) By Technology: Live Attenuated Vaccines, Inactivated Viral or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines
3) By Application: Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis
4) By End Users: Healthcare Firms, Hospitals
For further insights on the adult vaccines market,
request a sample here

Which region has the largest share of the adult vaccines market? What are the largest region's market size and growth rate?

North America was the largest region in the adult vaccines market in 2022. For detailed insights on the largest region's market size and growth rate, request a sample here.

Who are the major players in the adult vaccines market?

Key competitors in the adult vaccines market are, GlaxoSmithKline PLC, Merck & Co, Sanofi Pasteur, Pfizer Inc, CSL Limited, Johnson & Johnson, Serum Institute of India, AstraZeneca PLC, Novartis AG, Protein Sciences Corporation, Emergent BioSolutions Inc., Bavarian Nordic A/S, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo Company, Dynavax Technologies Corporation, ImmunoBiology Ltd., Novavax Inc. For further insights on the adult vaccines market, request a sample here.

What are the key trends in the adult vaccines market?

Major trends influencing the adult vaccines market include product innovations. Major companies in the market are introducing innovative products to sustain their position in the market. For further insights on the adult vaccines, request a sample here.

What are the major opportunities in the adult vaccines market? What are the strategies for the adult vaccines market?

For detailed insights on the major opportunities and strategies in the adult vaccines market, request a sample here.

How does the adult vaccines market relate to the overall economy and other similar markets?

For detailed insights on adult vaccines market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the adult vaccines industry?

For detailed insights on the mergers and acquisitions in the adult vaccines industry, request a sample here.

What are the key dynamics influencing the adult vaccines market growth? SWOT analysis of the adult vaccines market.

For detailed insights on the key dynamics influencing the adult vaccines market growth and SWOT analysis of the adult vaccines industry, request a sample here.